Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N1-(1-dimethylcarbamoyl-2-phenyl-ethyl)-2-oxo-n4-(2-pyridin-2-yl-ethyl)-succinamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
N1-(1-dimethylcarbamoyl–2–phenyl–ethyl)–2–oxo–N4–(2–pyridin–2–yl–ethyl)–succinamide is a synthetic small molecule compound belonging to the class of phenylalanine derivatives. It has been catalogued in chemical and drug databases as an experimental molecule, but there is no evidence of clinical use, approved indications, or detailed pharmacological characterization. Its mechanism of action, biological targets, and therapeutic applications are not described in public scientific resources. The compound is primarily referenced for research purposes and structural studies[1][6][7].
- Other names
- N1-(1-dimethylcarbamoyl-2-phenyl-ethyl)-2-oxo-n4-(2-pyridin-2-yl-ethyl)-succinamideN-[1-(dimethylcarbamoyl)-2-phenylet hyl]-2 -oxo-N'-[ 2 -(pyridin - 2 - yl) ethyl]butanediamideN-[ (1S) - 1 -(dimethylcarbamoyl ) - 2 - phenylethyl ] - 2 - oxo-N'-[ 2 -(pyridin - 2-y l ) ethy l ] butanediamide
02
Targets
CTSH (Cathepsin H)
Beyond the preview
Go deeper on N1-(1-dimethylcarbamoyl-2-phenyl-ethyl)-2-oxo-n4-(2-pyridin-2-yl-ethyl)-succinamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N1-(1-dimethylcarbamoyl-2-phenyl-ethyl)-2-oxo-n4-(2-pyridin-2-yl-ethyl)-succinamide.